Pharmaceutical & BioTech

RPN’s comprehensive Value & Access Strategy services allow pharmaceutical companies to navigate new markets and disease landscapes with confidence.

Our team of experts guides landscape assessments and stakeholder mapping, offering a clear understanding of key drivers and stakeholders, which form the foundation for creating robust market access plans that prioritize patient access.

RPN goes beyond simple identification and works towards building proactive and lasting relationships with relevant stakeholders, including healthcare professionals, patient advocacy groups, regulatory authorities, and payers.

Through collaborative advisory boards we facilitate open dialog and constructive feedback so that our clients’ strategies meet the needs and expectations of all stakeholders involved.

When it comes to pricing, we believe in a lean and effective pricing strategy that aligns with payer country needs, thus enhancing the product’s value proposition. From pricing strategy development to forecasting models and quantitative pricing research, we support both affiliates and headquarters throughout the pricing and negotiation process. With a strong track record of successful negotiations, we ensure dossiers that effectively illustrate the value added by products, so that our client can make impactful strides in the market.